Navigation Links
KTA Capital Advises SpringTree Global Investors on an AU$7.2 Million Investment in HealthLinx Ltd
Date:10/6/2009

HealthLinx Ltd (ASX:HTX), an Australian Securities Exchange-listed oncology biotechnology company, announced today an AU$7,230,000 investment by SpringTree Special Opportunities Fund, LP ("SpringTree"). KTA Capital, LLC ("KTA Capital") acted as the exclusive financial advisor to SpringTree's general partner SpringTree Global Investors, LLC on the transaction. A copy of KTA Capital's press release follows.

New York (PRWEB) October 6, 2009 -- HealthLinx Ltd (ASX:HTX), an Australian Securities Exchange-listed oncology biotechnology company, announced today an AU$7,230,000 investment by SpringTree Special Opportunities Fund, LP ("SpringTree"). KTA Capital, LLC acted as the exclusive financial advisor to SpringTree's general partner SpringTree Global Investors, LLC on the transaction. To view a copy of HealthLinx Ltd's public announcement please click here http://www.asx.com.au/asxpdf/20091005/pdf/31l4jfcj18pk2m.pdf.

About KTA Capital, LLC
KTA Capital is an investment bank headquartered in New York, USA. Its services include international investment banking across a wide range of industries, both in the equity capital and debt markets, as well as M&A advisory. In its business it leverages its relationships with literally hundreds of institutional investors, including hedge funds, mutual funds, private equity funds, venture capital funds, bond funds, mezzanine debt funds, private placement funds, investment advisers, national, regional and international banks, acquisitive industry participants and strategic cornerstone investors, family offices, merchant banks and sovereign wealth funds. KTA Capital is registered as a broker-dealer with the United States Securities and Exchange Commission and is a member of Financial Industry Regulatory
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. AtriCure to Present at Roth Capital Partners 2007 New York Conference
3. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
4. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
5. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
6. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
7. Pharsight Files Application for Nasdaq Capital Market Listing
8. Advanced Life Sciences Joins NASDAQ Capital Market
9. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
10. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
11. Caxton-Iseman Capital Acquires Conney Safety Products, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... ... Brands like Toppik , Eau Thermale Avene and Bliss are now available ... $49.00 was required to qualify for free standard shipping,” said Jennifer Ramirez, the public ... regardless of the item’s selling price.” , With competitive pricing in the e-commerce market ...
(Date:8/29/2015)... ... August 29, 2015 , ... ProDrop Particles includes over 40 particle backdrops ... seconds of unique footage that users can shrink and stretch in the Final Cut ... Users can customize color, brightness, scale, speed, range, and flare attributes with intuitive controls ...
(Date:8/29/2015)... ... August 29, 2015 , ... Hamstring strain have ... soft tissue manipulation. Platelet rich plasma injections also have mixed results. Building ... treatment outcomes. This localized treatment seems to address the symptoms and does ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... freely market and sell Arterosil and Arterosil HP, and that all claims and ... sued Vascular Health Sciences, LLC (VHS) in the United States District Court for ...
(Date:8/28/2015)... Madre, CA (PRWEB) , ... August 28, 2015 ... ... solutions to wound center management, Decatur County Memorial Hospital recently transitioned management companies ... model of Wound Center Management for their outpatient wound center. , Transitioning ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4
... 21 (HealthDay News) -- Physically unfit men who do heavy ... a new study says. It also found that income ... socioeconomic levels are more likely to have lifestyle risk factors ... in lower and higher socioeconomic levels. Thirty percent of the ...
... Ill. -- Many premature infants suffer a life-threatening ... a Loyola University Medical Center study has identified a ... blood type who develop NEC are nearly three times ... other blood types., The finding suggests that a simple ...
... A team of University of Missouri researchers have found that ... the severity of the disease Spinal Muscular Atrophy (SMA) ... "When we introduced synthetic RNA into mice that carry ... lowered," said Chris Lorson, researcher at the Bond Life Sciences ...
... HealthDay Reporter , MONDAY, Nov. 21 (HealthDay News) -- ... Monday issued new recommendations on breast cancer screening, and ... a U.S. governmental panel. As the U.S. Preventive ... government-appointed Canadian panel of experts is also suggesting that ...
... (HealthDay News) -- ,Death rates for U.S. patients with throat and ... The finding comes from an analysis of National Center for ... 25 to 64, in 26 states. The researchers also ... throat (pharynx) cancers were among black patients with at least 12 ...
... , MONDAY, Nov. 21 (HealthDay News) -- Young ... death decades later, according to a new study. High ... disease and stroke but most of the evidence supporting this ... For this investigation of the long-term impact of elevated ...
Cached Medicine News:Health News:Life-threatening condition in preemies linked to blood type 2Health News:New Canadian Guidelines Also Support No Routine Mammograms Until 50 2Health News:New Canadian Guidelines Also Support No Routine Mammograms Until 50 3Health News:Fewer Dying in U.S. From Throat, Mouth Cancer, Study Finds 2Health News:Hypertension in Young Adulthood May Mean Trouble Later On 2
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... announced the addition of the "Investigation Report on ... Tobramycin is a traditional antibiotic whose eye ... for the treatment of potential infection or inflammation caused ... China are able to produce tobramycin, ...
(Date:8/28/2015)... -- Research and Markets ( ... "Investigation Report on China,s Quetiapine Market, 2010-2019" ... by AstraZeneca plc, quetiapine (under the trade name ... treatment of schizophrenia. Approved by CFDA to treat ... Catalogue of Drugs for the Basic National Medical ...
(Date:8/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/sqh7xc/investigation ) ... on China,s Ranibizumab Market, 2012-2019" report to their ... by CFDA to treat wet age- related macular degeneration ... Novartis, is available in the Chinese market. However, in ... the treatment of wet AMD in China ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Quetiapine Market Investigation Report 2010-2019 2Investigation Report on China's Ranibizumab Market, 2012-2019 2
... CAMBRIDGE, Mass., March 18 Peptimmune, Inc. a ... its first,clinical trial to evaluate the safety, tolerability, ... for the treatment of,multiple sclerosis and other autoimmune ... double blind placebo controlled,randomized study involved 56 healthy ...
... of Pennsylvania shows promising results, ATLANTA, March ... increase milk production of dairy cows. A study ... School of,Veterinary Medicine (Penn Vet) indicates that improving ... has the potential to,produce the desired results., ...
Cached Medicine Technology:Peptimmune Completes Phase I Study with a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis 2Increasing Dairy Milk Production with Electrolyzed Drinking Water 2Increasing Dairy Milk Production with Electrolyzed Drinking Water 3Increasing Dairy Milk Production with Electrolyzed Drinking Water 4Increasing Dairy Milk Production with Electrolyzed Drinking Water 5
... Dissectron ultrasonic aspirator, ... ultrasonic surgical aspirator for ... of tissue available only ... Gathers in a very ...
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 5 mm....
Medicine Products: